GA, L., A, R., S, D., EB, S., SG, W., C, C., . . . CA, M. (2022). Predictors of myocardial fibrosis and response to anti-fibrotic therapy in heart failure with preserved ejection fraction. The international journal of cardiovascular imaging, 38(7), 1569. https://doi.org/10.1007/s10554-022-02544-9
Chicago Style (17th ed.) CitationGA, Lewis, Rosala-Hallas A, Dodd S, Schelbert EB, Williams SG, Cunnington C, McDonagh T, and Miller CA. "Predictors of Myocardial Fibrosis and Response to Anti-fibrotic Therapy in Heart Failure with Preserved Ejection Fraction." The International Journal of Cardiovascular Imaging 38, no. 7 (2022): 1569. https://doi.org/10.1007/s10554-022-02544-9.
MLA (9th ed.) CitationGA, Lewis, et al. "Predictors of Myocardial Fibrosis and Response to Anti-fibrotic Therapy in Heart Failure with Preserved Ejection Fraction." The International Journal of Cardiovascular Imaging, vol. 38, no. 7, 2022, p. 1569, https://doi.org/10.1007/s10554-022-02544-9.